The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
DepartmentsFull Access

Punding as a Cause of Death in a Patient With Parkinson’s Disease

To the Editor: L-dopa and dopamine agonists are used to treat motor symptoms of Parkinson’s disease (PA), but they may also cause motor and behavioral adverse events. These are consistent with motor fluctuations, dyskinesias, anxiety disorders, psychosis, and impulse control disorders. Punding is also an impulse control disorder, and here we present a 71-year-old patient with PA who died from secondary complications because of punding.

Case Report

A 71-year-old man with idiopathic PD was on L-dopa, pramipexole, amantadine, and rasagiline treatment for 10 years. He also had diabetes mellitus and hypertension but no history of alcohol or drug abuse. His daughter complained about his excessive fixing of furniture (sofa bed) and electronic devices (television and radios). The recommended treatment dose was 3 mg/day, but he had started using larger doses up to 12 mg/day of pramipexole and 750 mg/day of L-dopa with developing peak-dose dyskinesias and motor fluctuations for 3 years, and he stopped taking amantadine treatment. He said that he could not stop fixing objects because of his irresistible desire to repair them. He was diagnosed with impulse control disorder (ICD) and after stopping amantadine, his ICD was worse. Quetiapine 25 mg/day dose was given and increased to 400 mg/day, and pramipexole dose was gradually decreased to treat punding behaviors. However, there was no improvement with these treatments and punding behaviors continued. Two months later, his daughter found him trapped under a closed sofa bed in an unconscious state for 8 hours, resulting from head and neck trauma that he sustained while fixing the sofa bed. He was admitted to neurosurgery service, but he died from secondary complications after 2 weeks.

Impulse control disorders (ICD) are characterized by excessive shopping, pathologic gambling, hypersexuality, compulsive eating, and compulsive dopaminergic drug usage.1 These are important behaviors because they can cause personal, financial, and familial consequences.2 Punding is also a ICD, and it is a stereotypical motor behavior in which there is an intense fascination with repetitive handling and examining of mechanical objects, such as picking at oneself or taking apart watches and radios or sorting and arranging of common objects, such as lining up pebbles, rocks, or other small objects.3 Punding was a cause of death in our patient with PD.

It is known that decreasing dopamine exposure is an effective way to manage ICD that occurs during dopamine treatment. In one case report, a patient with PD presenting disabling punding was reversed by amantadine without aggravating motor function.4 Also, our patient’s punding behaviors had increased after stopping amantadine. In a study, it had been suggested that neural systems mediating the expression of dyskinesias and punding might overlap, and punding should sought systematically in PD patients presenting with disabling severe dyskinesias.5 We report this case because aside from personal, financial, and familial consequences, ICD and punding may sometimes cause death. This should be kept in mind in PD.

Dept. of Neurology, Bakirkoy Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul, Turkey
Dept. of Neurosurgery, Samatya Training and Research Hospital, Istanbul, Turkey
Send correspondence to Dr. Köksal; e-mail:

The authors report no financial relationships with commercial interests.

References

1 Voon V, Sohr M, Lang AE, et al.: Impulse control disorders in Parkinson disease: a multicenter case—control study. Ann Neurol 2011; 69:986–996Crossref, MedlineGoogle Scholar

2 Ceravolo R, Frosini D, Rossi C, et al.: Impulse control disorders in Parkinson’s disease: definition, epidemiology, risk factors, neurobiology and management. Parkinsonism Relat Disord 2009; 15(Suppl 4):S111–S115Crossref, MedlineGoogle Scholar

3 Fernandez HH, Friedman JH: Punding on L-dopa. Mov Disord 1999; 14:836–838Crossref, MedlineGoogle Scholar

4 Kashihara K, Imamura T. Amantadine may reverse punding in Parkinson’s disease—observation in a patient. Mov Disord 2008; 23:129–130Crossref, MedlineGoogle Scholar

5 Silveira-Moriyama L, Evans AH, Katzenschlager R, Lees AJ. Punding and dyskinesias. Mov Disord 2006; 21:2214–2217Crossref, MedlineGoogle Scholar